Anatara Lifesciences Ltd (ANR) — Cash Flow-to-Debt Ratio
Anatara Lifesciences Ltd (ANR) has a Cash Flow-to-Debt Ratio of -2.24x as of June 2025, meaning its operating cash flow of AU$-1.37 Million could theoretically repay -2% of its total liabilities (AU$612.42K) in one year. See Anatara Lifesciences Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anatara Lifesciences Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Anatara Lifesciences Ltd across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Anatara Lifesciences Ltd.
Annual Cash Flow-to-Debt Ratio for Anatara Lifesciences Ltd (2013–2025)
Year-by-year debt coverage analysis for Anatara Lifesciences Ltd. Check cash flow quality index of Anatara Lifesciences Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.71x | AU$-2.27 Million | AU$612.42K | ▲ +8.7% |
| 2024 | -4.07x | AU$-1.25 Million | AU$306.85K | ▲ +10.9% |
| 2023 | -4.56x | AU$-2.26 Million | AU$494.83K | ▲ +17.6% |
| 2022 | -5.54x | AU$-2.23 Million | AU$403.35K | ▼ -31.1% |
| 2021 | -4.22x | AU$-2.10 Million | AU$496.67K | ▲ +24.5% |
| 2020 | -5.60x | AU$-2.72 Million | AU$486.96K | ▼ -16.7% |
| 2019 | -4.79x | AU$-2.24 Million | AU$466.76K | ▼ -77.1% |
| 2018 | -2.71x | AU$-3.32 Million | AU$1.22 Million | ▲ +72.2% |
| 2017 | -9.74x | AU$-2.88 Million | AU$295.44K | ▼ -1445.1% |
| 2016 | -0.63x | AU$-280.37K | AU$444.62K | ▲ +95.2% |
| 2015 | -13.09x | AU$-1.92 Million | AU$146.98K | ▼ -366.2% |
| 2014 | -2.81x | AU$-639.27K | AU$227.62K | ▼ -459.4% |
| 2013 | -0.50x | AU$-177.22K | AU$352.96K | — |